These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28384360)

  • 1. Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.
    Nirvanappa AC; Mohan CD; Rangappa S; Ananda H; Sukhorukov AY; Shanmugam MK; Sundaram MS; Nayaka SC; Girish KS; Chinnathambi A; Zayed ME; Alharbi SA; Sethi G; Basappa ; Rangappa KS
    PLoS One; 2017; 12(4):e0175659. PubMed ID: 28384360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.
    Nirvanappa AC; Mohan CD; Rangappa S; Ananda H; Sukhorukov AY; Shanmugam MK; Sundaram MS; Nayaka SC; Girish KS; Chinnathambi A; Zayed ME; Alharbi SA; Sethi G; Basappa ; Rangappa KS
    PLoS One; 2016; 11(9):e0163209. PubMed ID: 27685808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: PAMs ameliorates the imiquimod-induced psoriasis-like skin disease in mice by inhibition of translocation of NF-κB and production of inflammatory cytokines.
    Dou R; Liu Z; Yuan X; Xiangfei D; Bai R; Bi Z; Yang P; Yang Y; Dong Y; Su W; Li D; Mao C
    PLoS One; 2018; 13(5):e0198501. PubMed ID: 29847604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: The thromboprotective effect of traditional Chinese medicine Tongji 2 granules is dependent on anti-inflammatory activity by suppression of NF-κB pathways.
    Zhou L; Lapping S; Liao X; Lu Y; Zhou G; Matoba K; Vasudevan NT; Wang L; Lalitha Nayak
    PLoS One; 2021; 16(4):e0250139. PubMed ID: 33831108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: NF-κB is activated in CD4+ iNKT cells by sickle cell disease and mediates rapid induction of adenosine A2A receptors.
    The
    PLoS One; 2015; 10(2):e0117760. PubMed ID: 25659149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells.
    Takada H; Imadome KI; Shibayama H; Yoshimori M; Wang L; Saitoh Y; Uota S; Yamaoka S; Koyama T; Shimizu N; Yamamoto K; Fujiwara S; Miura O; Arai A
    PLoS One; 2017; 12(8):e0182682. PubMed ID: 28763513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Wogonin Improves Histological and Functional Outcomes, and Reduces Activation of TLR4/NF-κB Signaling after Experimental Traumatic Brain Injury.
    Chen CC; Hung TH; Wang YH; Lin CW; Wang PY; Lee CY; Chen SF
    PLoS One; 2012; 7(12):. PubMed ID: 29161739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Retraction: Stiffening-Induced High Pulsatility Flow Activates Endothelial Inflammation via a TLR2/NF-κB Pathway.
    PLOS ONE Staff
    PLoS One; 2019; 14(8):e0221184. PubMed ID: 31393942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Retraction: Stiffening-Induced High Pulsatility Flow Activates Endothelial Inflammation via a TLR2/NF-κB Pathway.
    PLOS ONE Staff
    PLoS One; 2019; 14(10):e0224014. PubMed ID: 31600324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Genomic and Clinical Effects Associated with a Relaxation Response Mind-Body Intervention in Patients with Irritable Bowel Syndrome and Inflammatory Bowel Disease.
    Kuo B; Bhasin M; Jacquart J; Scult MA; Slipp L; Riklin EI; Lepoutre V; Comosa N; Norton BA; Dassatti A; Rosenblum J; Thurler AH; Surjanhata BC; Hasheminejad NN; Kagan L; Slawsby E; Rao SR; Macklin EA; Fricchione GL; Benson H; Libermann TA; Korzenik J; Denninger JW
    PLoS One; 2017; 12(2):e0172872. PubMed ID: 28222181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Intestinal mucosal injury induced by obstructive jaundice is associated with activation of TLR4/TRAF6/NF-κB pathways.
    Tian X; Zhao H; Zhang Z; Guo Z; Li W
    PLoS One; 2019; 14(12):e0227310. PubMed ID: 31877182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?
    PLOS ONE Staff
    PLoS One; 2017; 12(2):e0170865. PubMed ID: 28152078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort.
    Waljee AK; Wiitala WL; Govani S; Stidham R; Saini S; Hou J; Feagins LA; Khan N; Good CB; Vijan S; Higgins PDR
    PLoS One; 2018; 13(5):e0197341. PubMed ID: 29742165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease.
    Kamm F; Strauch U; Degenhardt F; Lopez R; Kunst C; Rogler G; Franke A; Klebl F; Rieder F
    PLoS One; 2018; 13(9):e0203709. PubMed ID: 30180207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Allele-specific DNA methylation of disease susceptibility genes in Japanese patients with inflammatory bowel disease.
    Chiba H; Kakuta Y; Kinouchi Y; Kawai Y; Watanabe K; Nagao M; Naito T; Onodera M; Moroi R; Kuroha M; Kanazawa Y; Kimura T; Shiga H; Endo K; Negoro K; Nagasaki M; Unno M; Shimosegawa T
    PLoS One; 2019; 14(2):e0212148. PubMed ID: 30721250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics.
    Huh G; Yoon H; Choi YJ; Shin CM; Park YS; Kim N; Lee DH; Kim JS
    PLoS One; 2019; 14(5):e0216768. PubMed ID: 31063486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: AMPK-Activated Protein Kinase Suppresses Ccr2 Expression by Inhibiting the NF-κB Pathway in RAW264.7 Macrophages.
    Kumase F; Takeuchi K; Morizane Y; Suzuki J; Matsumoto H; Kataoka K; Al-Moujahed A; Maidana DE; Miller JW; Vavvas DG
    PLoS One; 2024; 19(5):e0304894. PubMed ID: 38814938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
    Costa-Cabral S; Brough R; Konde A; Aarts M; Campbell J; Marinari E; Riffell J; Bardelli A; Torrance C; Lord CJ; Ashworth A
    PLoS One; 2017; 12(4):e0176578. PubMed ID: 28426773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.
    Williams AD; Korolkova OY; Sakwe AM; Geiger TM; James SD; Muldoon RL; Herline AJ; Goodwin JS; Izban MG; Washington MK; Smoot DT; Ballard BR; Gazouli M; M'Koma AE
    PLoS One; 2017; 12(12):e0189551. PubMed ID: 29211779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Hydrophobicity of Antifungal β-Peptides Is Associated with Their Cytotoxic Effect on In Vitro Human Colon Caco-2 and Liver HepG2 Cells.
    Mora-Navarro C; Méndez-Vega J; Caraballo-León J; Lee MR; Palecek S; Torres-Lugo M; Ortiz-Bermúdez P
    PLoS One; 2016; 11(6):e0157025. PubMed ID: 27253875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.